A citation-based method for searching scientific literature

Jeffrey A Bluestone, Jane H Buckner, Mark Fitch, Stephen E Gitelman, Shipra Gupta, Marc K Hellerstein, Kevan C Herold, Angela Lares, Michael R Lee, Kelvin Li, Weihong Liu, S Alice Long, Lisa M Masiello, Vinh Nguyen, Amy L Putnam, Mary Rieck, Peter H Sayre, Qizhi Tang. Sci Transl Med 2015
Times Cited: 501







List of co-cited articles
1207 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Administration of CD4+CD25highCD127- regulatory T cells preserves β-cell function in type 1 diabetes in children.
Natalia Marek-Trzonkowska, Malgorzata Mysliwiec, Anita Dobyszuk, Marcelina Grabowska, Ilona Techmanska, Jolanta Juscinska, Magdalena A Wujtewicz, Piotr Witkowski, Wojciech Mlynarski, Anna Balcerska,[...]. Diabetes Care 2012
275
24

Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up.
Natalia Marek-Trzonkowska, Małgorzata Myśliwiec, Anita Dobyszuk, Marcelina Grabowska, Ilona Derkowska, Jolanta Juścińska, Radosław Owczuk, Agnieszka Szadkowska, Piotr Witkowski, Wojciech Młynarski,[...]. Clin Immunol 2014
201
23

In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes.
Qizhi Tang, Kammi J Henriksen, Mingying Bi, Erik B Finger, Greg Szot, Jianqin Ye, Emma L Masteller, Hugh McDevitt, Mark Bonyhadi, Jeffrey A Bluestone. J Exp Med 2004
882
22

First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells.
Piotr Trzonkowski, Maria Bieniaszewska, Jolanta Juścińska, Anita Dobyszuk, Adam Krzystyniak, Natalia Marek, Jolanta Myśliwska, Andrzej Hellmann. Clin Immunol 2009
445
20

Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity.
Marco Romano, Giorgia Fanelli, Caraugh Jane Albany, Giulio Giganti, Giovanna Lombardi. Front Immunol 2019
193
19

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.
Claudio G Brunstein, Jeffrey S Miller, Qing Cao, David H McKenna, Keli L Hippen, Julie Curtsinger, Todd Defor, Bruce L Levine, Carl H June, Pablo Rubinstein,[...]. Blood 2011
721
18

A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation.
Satoru Todo, Kenichiro Yamashita, Ryoichi Goto, Masaaki Zaitsu, Akihisa Nagatsu, Tetsu Oura, Masaaki Watanabe, Takeshi Aoyagi, Tomomi Suzuki, Tsuyoshi Shimamura,[...]. Hepatology 2016
209
17

Treg cell-based therapies: challenges and perspectives.
Caroline Raffin, Linda T Vo, Jeffrey A Bluestone. Nat Rev Immunol 2020
120
17


Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor.
Katherine G MacDonald, Romy E Hoeppli, Qing Huang, Jana Gillies, Dan S Luciani, Paul C Orban, Raewyn Broady, Megan K Levings. J Clin Invest 2016
218
16

Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials.
Birgit Sawitzki, Paul N Harden, Petra Reinke, Aurélie Moreau, James A Hutchinson, David S Game, Qizhi Tang, Eva C Guinan, Manuela Battaglia, William J Burlingham,[...]. Lancet 2020
92
16

Next-generation regulatory T cell therapy.
Leonardo M R Ferreira, Yannick D Muller, Jeffrey A Bluestone, Qizhi Tang. Nat Rev Drug Discov 2019
127
15

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.
Jason D Fontenot, Marc A Gavin, Alexander Y Rudensky. Nat Immunol 2003
14

Prevention of Allograft Rejection by Use of Regulatory T Cells With an MHC-Specific Chimeric Antigen Receptor.
F Noyan, K Zimmermann, M Hardtke-Wolenski, A Knoefel, E Schulde, R Geffers, M Hust, J Huehn, M Galla, M Morgan,[...]. Am J Transplant 2017
121
13

Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect.
Claudio G Brunstein, Jeffrey S Miller, David H McKenna, Keli L Hippen, Todd E DeFor, Darin Sumstad, Julie Curtsinger, Michael R Verneris, Margaret L MacMillan, Bruce L Levine,[...]. Blood 2016
213
13

Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation.
Alberto Sánchez-Fueyo, Gavin Whitehouse, Nathali Grageda, Matthew E Cramp, Tiong Y Lim, Marco Romano, Sarah Thirkell, Katie Lowe, Laura Fry, Julie Heward,[...]. Am J Transplant 2020
60
21

Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial.
Agnès Hartemann, Gilbert Bensimon, Christine A Payan, Sophie Jacqueminet, Olivier Bourron, Nathalie Nicolas, Michèle Fonfrede, Michelle Rosenzwajg, Claude Bernard, David Klatzmann. Lancet Diabetes Endocrinol 2013
241
13

Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants.
S Chandran, Q Tang, M Sarwal, Z G Laszik, A L Putnam, K Lee, J Leung, V Nguyen, T Sigdel, E C Tavares,[...]. Am J Transplant 2017
100
13

A Phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in Living Donor Kidney Transplants.
James M Mathew, Jessica H-Voss, Ann LeFever, Iwona Konieczna, Cheryl Stratton, Jie He, Xuemei Huang, Lorenzo Gallon, Anton Skaro, Mohammed Javeed Ansari,[...]. Sci Rep 2018
95
12

Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.
D A Boardman, C Philippeos, G O Fruhwirth, M A A Ibrahim, R F Hannen, D Cooper, F M Marelli-Berg, F M Watt, R I Lechler, J Maher,[...]. Am J Transplant 2017
129
12

Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis.
Graham P Wright, Clare A Notley, Shao-An Xue, Gavin M Bendle, Angelika Holler, Ton N Schumacher, Michael R Ehrenstein, Hans J Stauss. Proc Natl Acad Sci U S A 2009
135
12

Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease.
Pierre Desreumaux, Arnaud Foussat, Matthieu Allez, Laurent Beaugerie, Xavier Hébuterne, Yoram Bouhnik, Maria Nachury, Valérie Brun, Hervé Bastian, Nathalie Belmonte,[...]. Gastroenterology 2012
226
12

Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells.
Dan Blat, Ehud Zigmond, Zoya Alteber, Tova Waks, Zelig Eshhar. Mol Ther 2014
111
12

Control of regulatory T cell development by the transcription factor Foxp3.
Shohei Hori, Takashi Nomura, Shimon Sakaguchi. Science 2003
12

Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo.
Xuyu Zhou, Samantha L Bailey-Bucktrout, Lukas T Jeker, Cristina Penaranda, Marc Martínez-Llordella, Meredith Ashby, Maki Nakayama, Wendy Rosenthal, Jeffrey A Bluestone. Nat Immunol 2009
896
11

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation.
Mauro Di Ianni, Franca Falzetti, Alessandra Carotti, Adelmo Terenzi, Flora Castellino, Elisabetta Bonifacio, Beatrice Del Papa, Tiziana Zei, Roberta Iacucci Ostini, Debora Cecchini,[...]. Blood 2011
735
11

Generation of human islet-specific regulatory T cells by TCR gene transfer.
Caroline M Hull, Lauren E Nickolay, Megan Estorninho, Max W Richardson, James L Riley, Mark Peakman, John Maher, Timothy I M Tree. J Autoimmun 2017
62
17

Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation.
A L Putnam, N Safinia, A Medvec, M Laszkowska, M Wray, M A Mintz, E Trotta, G L Szot, W Liu, A Lares,[...]. Am J Transplant 2013
183
11

Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.
James B Canavan, Cristiano Scottà, Anna Vossenkämper, Rimma Goldberg, Matthew J Elder, Irit Shoval, Ellen Marks, Emilie Stolarczyk, Jonathan W Lo, Nick Powell,[...]. Gut 2016
116
11

Regulatory T cells in autoimmune disease.
Margarita Dominguez-Villar, David A Hafler. Nat Immunol 2018
225
10

Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease.
Christoph T Ellebrecht, Vijay G Bhoj, Arben Nace, Eun Jung Choi, Xuming Mao, Michael Jeffrey Cho, Giovanni Di Zenzo, Antonio Lanzavecchia, John T Seykora, George Cotsarelis,[...]. Science 2016
272
10

Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3.
Sarah E Allan, Alicia N Alstad, Natacha Merindol, Natasha K Crellin, Mario Amendola, Rosa Bacchetta, Luigi Naldini, Maria Grazia Roncarolo, Hugo Soudeyns, Megan K Levings. Mol Ther 2008
163
10

CD4⁺ T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer.
Laura Passerini, Eva Rossi Mel, Claudia Sartirana, Georgia Fousteri, Attilio Bondanza, Luigi Naldini, Maria Grazia Roncarolo, Rosa Bacchetta. Sci Transl Med 2013
84
11

Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes.
Natalia Marek-Trzonkowska, Małgorzata Myśliwiec, Dorota Iwaszkiewicz-Grześ, Mateusz Gliwiński, Ilona Derkowska, Magdalena Żalińska, Maciej Zieliński, Marcelina Grabowska, Hanna Zielińska, Karolina Piekarska,[...]. J Transl Med 2016
50
18

Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?
Caroline M Hull, Mark Peakman, Timothy I M Tree. Diabetologia 2017
67
13

Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial.
Michelle Rosenzwajg, Roberta Lorenzon, Patrice Cacoub, Hang Phuong Pham, Fabien Pitoiset, Karim El Soufi, Claire RIbet, Claude Bernard, Selim Aractingi, Beatrice Banneville,[...]. Ann Rheum Dis 2019
130
9

Transplant trials with Tregs: perils and promises.
Qizhi Tang, Flavio Vincenti. J Clin Invest 2017
90
10

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction.
Qizhi Tang, Jason Y Adams, Cristina Penaranda, Kristin Melli, Eliane Piaggio, Evridiki Sgouroudis, Ciriaco A Piccirillo, Benoit L Salomon, Jeffrey A Bluestone. Immunity 2008
547
9

CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery.
Moa Fransson, Elena Piras, Joachim Burman, Berith Nilsson, Magnus Essand, Binfeng Lu, Robert A Harris, Peetra U Magnusson, Eva Brittebo, Angelica S I Loskog. J Neuroinflammation 2012
144
9


Successful expansion of functional and stable regulatory T cells for immunotherapy in liver transplantation.
Niloufar Safinia, Trishan Vaikunthanathan, Henrieta Fraser, Sarah Thirkell, Katie Lowe, Laura Blackmore, Gavin Whitehouse, Marc Martinez-Llordella, Wayel Jassem, Alberto Sanchez-Fueyo,[...]. Oncotarget 2016
82
10

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
WanJun Chen, Wenwen Jin, Neil Hardegen, Ke-Jian Lei, Li Li, Nancy Marinos, George McGrady, Sharon M Wahl. J Exp Med 2003
9

Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.
Michel Tenspolde, Katharina Zimmermann, Leonie C Weber, Martin Hapke, Maren Lieber, Janine Dywicki, Andre Frenzel, Michael Hust, Melanie Galla, Laura E Buitrago-Molina,[...]. J Autoimmun 2019
38
23

CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes.
Kristin V Tarbell, Sayuri Yamazaki, Kara Olson, Priscilla Toy, Ralph M Steinman. J Exp Med 2004
529
9

FOXP3+ regulatory T cells in the human immune system.
Shimon Sakaguchi, Makoto Miyara, Cristina M Costantino, David A Hafler. Nat Rev Immunol 2010
9

Regulatory T cells and immune tolerance.
Shimon Sakaguchi, Tomoyuki Yamaguchi, Takashi Nomura, Masahiro Ono. Cell 2008
9

A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials.
Henrieta Fraser, Niloufar Safinia, Nathali Grageda, Sarah Thirkell, Katie Lowe, Laura J Fry, Cristiano Scottá, Andrew Hope, Christopher Fisher, Rachel Hilton,[...]. Mol Ther Methods Clin Dev 2018
52
15

Plasticity of human regulatory T cells in healthy subjects and patients with type 1 diabetes.
Stephanie A McClymont, Amy L Putnam, Michael R Lee, Jonathan H Esensten, Weihong Liu, Maigan A Hulme, Ulrich Hoffmüller, Udo Baron, Sven Olek, Jeffrey A Bluestone,[...]. J Immunol 2011
276
8

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.
Silvia Deaglio, Karen M Dwyer, Wenda Gao, David Friedman, Anny Usheva, Anna Erat, Jiang-Fan Chen, Keiichii Enjyoji, Joel Linden, Mohamed Oukka,[...]. J Exp Med 2007
8

Gene editing to induce FOXP3 expression in human CD4+ T cells leads to a stable regulatory phenotype and function.
Yuchi Honaker, Nicholas Hubbard, Yufei Xiang, Logan Fisher, David Hagin, Karen Sommer, Yumei Song, Soo Jung Yang, Christina Lopez, Tori Tappen,[...]. Sci Transl Med 2020
26
30


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.